Side-by-Side Comparison
| Metric | ARTBIO | Endocyte |
|---|---|---|
| Founded | ||
| Founded | 2021 | 1996 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | West Lafayette, United States |
| Employees | ||
| Employees | 74 larger | 16 |
| Industry | ||
| Industry | Biotechnology, Health Care, Medical Devices | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series B | Debt Financing |
| Total Funding | ||
| Total Funding | $245.00M | $114.35M |
| Funding Rounds | ||
| Funding Rounds | 3 | 7 |
| Services | ||
| Services | Development of Alpha Radioligand Therapies, Clinical Research and Trials, Manufacturing Ecosystem for Therapy Solutions | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer Patients, Oncologists, Healthcare Providers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Alpha Radioligand Therapies, Radiopharmaceuticals, Clinical-stage, Cancer Care, Precision Medicine, Pb-212 Isotope Technology, Therapeutic Development, Oncology, Innovative Medicine, Patient-centered Care, Isotope Supply Chain, Radioligand Ecosystem | Biopharmaceutical, Cancer Treatment, Targeted Therapies, Drug Conjugation Technology, PSMA-targeted Radioligand Therapy, MCRPC, Clinical Trials, CAR T-cell Therapy, Oncology, Precision Medicine |
| Website | ||
| Website | artbio.com | endocyte.com |
About ARTBIO
ARTBIO, founded in 2021 and based in the United States, is pioneering a paradigm shift in cancer treatment. Their focus on developing Alpha Radioligand Therapies (ARTs) leverages unique Pb-212 isotope technology, aiming to offer transformative solutions in oncology. The company’s mantra, “Channeling...
About Endocyte
Endocyte is a biopharmaceutical company and a leader in developing targeted therapies for the personalized treatment of cancer. The company's drug conjugation technology targets therapeutics and companion imaging agents specifically to the site of diseased cells. Endocyte's lead program is a prostat...
We will tell you when either one moves
BounceWatch watches ARTBIO and Endocyte for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ARTBIO and Endocyte — by email.
Frequently Asked Questions
Compare ARTBIO with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at ARTBIO on 9 Jun 2026, and Endocyte on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.